Adverum Biotechnologies, Inc.
The role involves leading scientific communication initiatives, overseeing the development and review of publications, presentations, and educational materials, and collaborating with cross‑functional teams to ensure high‑quality scientific output. It requires expertise in medical writing, data analysis, and strategic planning within a research and development environment.
Headquarters
Redwood City, California, United States
Company Size
51-200 employees
Founded
2012
Adverum Biotechnologies is a clinical‑stage biotechnology company focused on developing ocular gene therapies to treat debilitating retinal diseases. The company aims to establish ocular gene therapy as a new standard of care by advancing in vivo gene‑delivery approaches (using viral vectors) to preserve or restore vision. Adverum advances multiple preclinical and clinical programs with an emphasis on translational science, regulatory engagement, and patient impact. Their tagline: "Redefining sight for life."
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Adverum Biotechnologies, Inc..
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
Oct 27, 2025
Senior Director, Global Scientific Communications
Annexon Biosciences
Scientific Director – Publications
Nucleus Global
Director, Scientific Publications
Celldex Therapeutics
Director, Medical Publications and Scientific Communications
Replimune
Director, Scientific Writing
AstraZeneca
Senior Manager, Medical & Scientific Affairs
ANI Pharmaceuticals